Search

Phage therapy was covered in ‘Grow by Ginkgo’ magazine’s Scale issue; well-researched piece with a great narrative! Good one to share with public audiences, and highlights that the synthetic biology / biomanufacturing community is starting

Phages seem to be saving lives left and right, but still, they remain unapproved drugs in most countries. Pharma companies don't sell them; hospitals and pharmacies don’t stock them. In this Wired article, Maryn McKenna covers phage therapy

Microbiome Times analysed its Microbiome Drug Database™, a repository of biotechs developing microbiome drugs, for phage-related drugs. They found that almost 70% of the total of 100 company-sponsored, phage-based drug development programs

Great in-depth narrative article in The New Yorker magazine by Nicola Twilley, which details accounts of phage therapy patients treated recently in the US, as well as the behind-the-scenes work by scientists and doctors that goes into isola